Cancer Treatment and End-of-Life Care

被引:2
|
作者
Sinha, Sudha [1 ]
Matharu, Jaskirt Kaur [2 ]
Jacob, Jean [3 ,4 ]
Palat, Gayatri [4 ,5 ]
Brun, Eva [6 ]
Wiebe, Thomas [7 ]
Segerlantz, Mikael [8 ]
机构
[1] MNJ Inst Oncol & Reg Canc Ctr, Med Oncol, Hyderabad, Andhra Prades, India
[2] Lund Univ, Fac Med, Lund, Sweden
[3] Two Worlds Canc Collaborat INCTR Canada, Vancouver, BC, Canada
[4] MNJ Inst Oncol & Reg Canc Ctr, Pain & Palliat Med Dept, Hyderabad, Andhra Prades, India
[5] Two Worlds Canc Collaborat INCTR Canada, Palliat Access PAX Program India, Vancouver, BC, Canada
[6] Lund Univ, Skane Univ Hosp, Oncol, Dept Clin Sci Lund, Lund, Sweden
[7] Lund Univ, Skane Univ Hosp, Paediat, Dept Clin Sci Lund, Lund, Sweden
[8] Lund Univ, Inst Palliat Care, Fac Med, Dept Clin Sci Lund, Lund, Sweden
关键词
cancer; end-of-life; low/middle-income countries; specialized palliative care; tumor-specific treatment; CELL LUNG-CANCER; PALLIATIVE CARE; CHEMOTHERAPY USE; QUALITY; ONCOLOGY; AGGRESSIVENESS; DEATH; MORTALITY; INDIA;
D O I
10.1089/jpm.2017.0695
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aim: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India. Patients and Methods: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled. Results: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients. Conclusions: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).
引用
收藏
页码:1100 / 1106
页数:7
相关论文
共 50 条
  • [1] Aggressiveness of end-of-life cancer care: what happens in clinical practice?
    Garcia-Martin, Estela
    Escudero-Vilaplana, Vicente
    Fox, Barbara
    Collado-Borrell, Roberto
    Marzal-Alfaro, Belen
    Sanchez-Isac, Maria
    Solano-Garzon, Maria Luisa
    Gonzalez del Val, Ricardo
    Cano-Gonzalez, Jose Manuel
    Perez de Lucas, Nuria
    Bravo-Guillen, Ana Isabel
    Valero-Salinas, Javier
    Gonzalez-Haba, Eva
    Sanjurjo, Maria
    Martin, Miguel
    SUPPORTIVE CARE IN CANCER, 2021, 29 (06) : 3121 - 3127
  • [2] Intensity of treatment in Swiss cancer patients at the end-of-life
    Bahler, Caroline
    Signorell, Andri
    Blozik, Eva
    Reich, Oliver
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 481 - 491
  • [3] Understanding the Views of Those Who Care for Patients With Cancer on Advance Care Planning and End-of-life Care
    Mattes, Malcolm D.
    Tung, Kaity
    Baum, Rachel
    Parikh, Kapila
    Ashamalla, Hani
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2015, 32 (08): : 802 - 809
  • [4] Evaluating aggressiveness of end-of-life care in patients with advanced cancer: A retrospective single-center analysis
    Iglesias-Santamaria, Araceli
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022,
  • [5] Palliative care interventions and end-of-life care for patients with metastatic breast cancer: a multicentre analysis
    Lucchi, Elisabeth
    Berger, Frederique
    Milder, Maude
    Commer, Jean-Marie
    Morin, Sophie
    Capodano, Geraldine
    Thomaso, Muriel
    Fogliarini, Anne
    Bremaud, Nathalie
    Henry, Aline
    Mastroianni, Benedicte
    Chvetzoff, Gisele
    Bouleuc, Carole
    ONCOLOGIST, 2024, : e708 - e715
  • [6] End-of-Life Care in Medicare Beneficiaries Dying With Pancreatic Cancer
    Sheffield, Kristin M.
    Boyd, Casey A.
    Benarroch-Gampel, Jamie
    Kuo, Yong-Fang
    Cooksley, Catherine D.
    Riall, Taylor S.
    CANCER, 2011, 117 (21) : 5003 - 5012
  • [7] Palliative, Ethics, and End-of-Life Care Issues in the Cancer Patient
    Riches, Jamie C.
    Voigt, Louis P.
    CRITICAL CARE CLINICS, 2021, 37 (01) : 105 - 115
  • [8] Suffering and distress at the end-of-life
    Krikorian, Alicia
    Limonero, Joaquin T.
    Mate, Jorge
    PSYCHO-ONCOLOGY, 2012, 21 (08) : 799 - 808
  • [9] The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life
    Palaia, Innocenza
    Tomao, Federica
    Santangelo, Giusi
    Di Pinto, Anna
    Sassu, Carolina Maria
    Perniola, Giorgia
    Musella, Angela
    Di Donato, Violante
    Giancotti, Antonella
    Benedetti Panici, Pierluigi
    ONCOLOGY, 2019, 97 (05) : 306 - 310
  • [10] Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer
    Lopez-Acevedo, Micael
    Havrilesky, Laura J.
    Broadwater, Gloria
    Kamal, Arif H.
    Abernethy, Amy P.
    Berchuck, Andrew
    Secord, Angeles Alvarez
    Tulsky, James A.
    Valea, Fidel
    Lee, Paula S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 156 - 161